SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-052224
Filing Date
2020-11-09
Accepted
2020-11-09 08:13:55
Documents
14
Period of Report
2020-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K urgn-8k_20201109.htm   iXBRL 8-K 48168
2 EX-99.1 urgn-ex991_6.htm EX-99.1 179272
3 GRAPHIC gexro0zitarn000001.jpg GRAPHIC 46157
  Complete submission text file 0001564590-20-052224.txt   435725

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA urgn-20201109.xsd EX-101.SCH 5768
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20201109_lab.xml EX-101.LAB 19469
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20201109_pre.xml EX-101.PRE 11624
7 EXTRACTED XBRL INSTANCE DOCUMENT urgn-8k_20201109_htm.xml XML 3571
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38079 | Film No.: 201296205
SIC: 2834 Pharmaceutical Preparations